Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Delivers 450 mg of reduced glutathione per serving*
A comprehensive review in MDPI Pharmaceuticals reviewing research through 2025 further listed GLP-1 induction as one of berberine's key documented mechanisms in managing type 2 diabetes and metabolic disease
Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS
Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like Peptide-1
Spermidine-mediated induction of autophagy requires that the pro-autophagic transcription factor identified as TFEB (transcription factor EB, where the EB refers to enhancer box binding site) be activated
To inject 0.5mg, draw 0.1mL (10 units on a 100-unit syringe)
US$ 28.46
US$ 26.12
US$ 24.83
US$ 27.18
